youklip

The Dark Side of Psychedelics and Corporate Interests

Carl Hayden Smith critiques the commercialization of psychedelics, warning that billion-dollar corporations are poised to profit from FDA regulations. He emphasizes the danger of these companies prioritizing profit over genuine healing, creating a system that commodifies mental health solutions.

AI-generated summary — may contain errors. How it works

sparkles Artificial IntelligenceDanny Jones7:58

Get clips like this delivered to your feed — follow topics and channels you care about.

Join YouKlip — Free